Silverfin false false 30/11/2025 30/11/2025 01/12/2024 no description of principal activity John Thomas Patrick Gentry 18/08/2020 12819767 2025-11-30 12819767 bus:Director1 2025-11-30 12819767 2024-11-30 12819767 core:CurrentFinancialInstruments 2025-11-30 12819767 core:CurrentFinancialInstruments 2024-11-30 12819767 2024-12-01 2025-11-30 12819767 bus:Micro-entities 2024-12-01 2025-11-30 12819767 bus:FilletedAccounts 2024-12-01 2025-11-30 12819767 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 12819767 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 12819767 bus:Director1 2024-12-01 2025-11-30 12819767 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure

Company No: 12819767 (England and Wales)

GENO HOLDINGS LIMITED

Unaudited Financial Statements
For the financial year ended 30 November 2025
Pages for filing with the registrar

GENO HOLDINGS LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 30 November 2025

Contents

GENO HOLDINGS LIMITED

COMPANY INFORMATION

For the financial year ended 30 November 2025
GENO HOLDINGS LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 30 November 2025
DIRECTOR John Thomas Patrick Gentry
REGISTERED OFFICE Ground Floor Keble House
Southernhay Gardens
Exeter
EX1 1NT
United Kingdom
COMPANY NUMBER 12819767 (England and Wales)
ACCOUNTANT Gravita Western Limited
Keble House
Southernhay Gardens
Exeter
EX1 1NT
United Kingdom
GENO HOLDINGS LIMITED

BALANCE SHEET

As at 30 November 2025
GENO HOLDINGS LIMITED

BALANCE SHEET (continued)

For the financial year ended 30 November 2025
2025 2024
£ £
Fixed assets 2,074,974 2,054,974
Current assets 415,410 274,957
Creditors: amounts falling due within one year - ( 124)
Net current assets 415,410 274,833
Total assets less current liabilities 2,490,384 2,329,807
Accruals and deferred income ( 2,325) ( 2,340)
Net assets 2,488,059 2,327,467
Capital and reserves 2,488,059 2,327,467

For the financial year ending 30 November 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Geno Holdings Limited (registered number: 12819767) were approved and authorised for issue by the director on 26 August 2026 and were signed on its behalf by:

John Thomas Patrick Gentry
Director
GENO HOLDINGS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 November 2025
GENO HOLDINGS LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 30 November 2025

1. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the financial year, including the director 1 1

2. Directors’ benefits: advances, credit and guarantees

Advances

During the year, the company made advances to a director. At 30 November 2025, the balance outstanding on the director's loan account was £6,748 (2024: £33,987). The loan was repayable on demand and interest has been charged at the HM Revenue and Customs official rate.